Results 181 to 190 of about 263,614 (309)

The Hidden Burden of Hemifacial Spasm: A Systematic Review of Non‐Motor Symptoms

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Hemifacial spasm (HFS) is a chronic neurological disorder characterized by involuntary contractions of facial muscles. Traditionally regarded as a motor condition, HFS encompasses a spectrum of non‐motor symptoms that are often overlooked but significantly affect patients’ quality of life.
Miriam Carvalho Soares, Jacy Bezerra Parmera, Pedro Augusto Sampaio Rocha‐Filho   +2 more
wiley   +1 more source

Pharmacokinetic-Pharmacodynamic Model of Paclitaxel-Induced Peripheral Neuropathy. [PDF]

Clin Transl Sci
Sun Y, Pai MP, Henry NL, Hertz DL.
europepmc   +1 more source

Structural and Functional Impact of Spinal Cord Stimulation in Diabetic Peripheral Neuropathy. [PDF]

Cureus
Almosawi M, Shanti R, Hill N, Gartner K, Ahn B, Fernández-Gajardo R, van Wouwe N, Pulla M, Ford T, Ahn N, Zemmar A.   +10 more
europepmc   +1 more source

Brentuximab-Induced Peripheral Neuropathy in the Setting of Radiation-Induced Brachial Plexopathy. [PDF]

Cureus
Gu A, Masturov Y, Rekant M, Miller A.
europepmc   +1 more source

Exocrine Gland Dysfunction in Parkinson's Disease: Pathophysiology, Clinical Manifestations, and Therapeutic Perspectives—A Narrative Review

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Non‐motor symptoms, especially autonomic dysfunction, are major contributors to disability and decreased quality of life in Parkinson's disease (PD). Despite being common and having a wide range of clinical facets, exocrine gland dysfunction is still not well recognized and managed.
Renato P. Munhoz, Marina Farah, Laura Silveira‐Moriyama   +2 more
wiley   +1 more source

FXTAS and the Spectrum of FMR1 Premutation‐Associated Phenotypes in Latin America: A Scoping Review

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Fragile X–associated tremor/ataxia syndrome (FXTAS) is a late‐onset neurodegenerative disorder caused by FMR1 premutation expansions (55–200 CGG repeats). Although well described in populations of predominantly European ancestry, FXTAS remains poorly characterized in Latin America due to limited awareness, restricted access to ...
Amy Schmidmajer, Salomón Páez‐García, Santiago Martínez, Jacobo Ramírez‐Triana, Kevin O'Hara‐Veintimilla, Andrés Ricaurte‐Fajardo, Catalina Cerquera‐Cleves   +6 more
wiley   +1 more source

Response to Comments on "Feasibility of Viscosity Imaging and Shear Wave Elastography for Diagnosing Diabetic Peripheral Neuropathy". [PDF]

Korean J Radiol
Tan S, Zhao S, Jin Z, Yao J, Wang W, Li C, Zhang W.   +6 more
europepmc   +1 more source

Gait as a quantitative indicator of the severity of chemotherapy-induced peripheral neuropathy: a pilot study. [PDF]

Support Care Cancer
Kim SJ, Dougherty P, Abdi S, Javed S.
europepmc   +1 more source

Cardiac MIBG Scintigraphy in Neurodegenerative Parkinsonism: Limitations in Clinical Practice

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Reduced cardiac uptake on 123Iodine‐metaiodobenzylguanidine (MIBG) scintigraphy is a valuable tool for differentiating neurodegenerative parkinsonism but interpretation can be difficult due to comorbidities and drug‐tracer interactions.
Frank Jagusch, Elena Redl, Christoph Theyer, Atbin Djamshidian, Alessandra Fanciulli, Werner Poewe, Philipp Mahlknecht, Beatrice Heim, Klaus Seppi, Florian Krismer   +9 more
wiley   +1 more source

Mitochondrial transfer from glia to neurons protects against peripheral neuropathy. [PDF]

Nature
Xu J, Li Y, Novak C, Lee M, Yan Z, Bang S, McGinnis A, Chandra S, Zhang V, He W, Lechler T, Rodriguez Salazar MP, Eroglu C, Becker ML, Velmeshev D, Cheney RE, Ji RR.   +16 more
europepmc   +1 more source